Dr. Schabacker currently serves as Corporate Vice President and Chief Scientific Officer at Baxter Healthcare Corporation. In this role, he leads the Research & Development (R&D), Regulatory Affairs, Program Management Office, Global Patient Safety, Medical Affairs, Life Science and Clinical Development organizations for Baxter. He is responsible for driving innovation, enhancing scientific technical and medical capabilities to ensure a strong foundation of safety, clinical development, and regulatory support.
Prior to his appointment as CSO, Dr. Schabacker joined Baxter in March 2011 as the head of R&D for Baxter’s Medical Products business unit. He led the integration of multiple R&D teams into one global organization and placed R&D resources closer to its global customer base, including those in fast- growing emerging markets such as China and India.
Before joining Baxter, Dr. Schabacker held the position of Senior Vice President and Chief Scientific Officer at ConvaTec, Inc. – a leading developer and marketer of medical technologies in ostomy care, wound therapeutics, continence and critical care, and infusion devices. Dr. Schabacker’ s previous roles include Corporate Vice President R&D at B. Braun Medical and Senior Medical Officer at Mafikeng General Hospital, South Africa where he established and led the Anesthesia and Intensive Care Medicine Department and also served as the Medical Lead for Disaster Planning.
Dr. Schabacker has an MD and a Doctorate in anesthesia from Medical University of Lübeck in Germany and certifications in Anesthesiology, Disaster Medicine, and Emergency Medicine.